Insider · CIK 0001691494
Semigran Marc
officer
Files at EWTX (Edgewise Therapeutics, Inc.). First filing Dec 27, 2024, latest Dec 27, 2024.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $882k sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Side | Company | Value | Shares | Holdings change | Price context | Filed |
|---|---|---|---|---|---|---|---|
| 31Weak | sell 210b5-1 | EWTX Edgewise Therapeutics, Inc. | $882k | 29,709 | -82% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 24, 2024 | EWTX Edgewise Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +29,709 | $8.94 | $266k | 36,425 | Dec 27, 2024 |
| Dec 24, 2024 | EWTX Edgewise Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -27,980 | $29.66 | $830k | 8,445 | Dec 27, 2024 |
| Dec 24, 2024 | EWTX Edgewise Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -1,729 | $30.08 | $52k | 6,716 | Dec 27, 2024 |
| Dec 24, 2024 | EWTX Edgewise Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -29,709 | $0.00 | $0 | 270,291 | Dec 27, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.